Cargando...
Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients
OBJECTIVE: Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation. Although fingolimod-associated lymphopenia is a well-known phenomenon, the exact cause...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256977/ https://ncbi.nlm.nih.gov/pubmed/30524432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02669 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|